Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP404805.RASwMfErNTP5Dc5oXGjVT594S-kM2BXOo-EfrZogdYqBk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP404805.RASwMfErNTP5Dc5oXGjVT594S-kM2BXOo-EfrZogdYqBk130_assertion type Assertion NP404805.RASwMfErNTP5Dc5oXGjVT594S-kM2BXOo-EfrZogdYqBk130_head.
- NP404805.RASwMfErNTP5Dc5oXGjVT594S-kM2BXOo-EfrZogdYqBk130_assertion description "[To better understand factors regulating TPO levels, we measured blood levels of TPO in patients with impaired platelet production due to aplastic anemia (AA) and with platelet destructive disorders, including idiopathic thrombocytopenic purpura (ITP), posttransfusion purpura (PTP), drug purpura (DP), and X-linked thrombocytopenia (XLTP).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP404805.RASwMfErNTP5Dc5oXGjVT594S-kM2BXOo-EfrZogdYqBk130_provenance.
- NP404805.RASwMfErNTP5Dc5oXGjVT594S-kM2BXOo-EfrZogdYqBk130_assertion evidence source_evidence_literature NP404805.RASwMfErNTP5Dc5oXGjVT594S-kM2BXOo-EfrZogdYqBk130_provenance.
- NP404805.RASwMfErNTP5Dc5oXGjVT594S-kM2BXOo-EfrZogdYqBk130_assertion SIO_000772 8639762 NP404805.RASwMfErNTP5Dc5oXGjVT594S-kM2BXOo-EfrZogdYqBk130_provenance.
- NP404805.RASwMfErNTP5Dc5oXGjVT594S-kM2BXOo-EfrZogdYqBk130_assertion wasDerivedFrom befree-20140225 NP404805.RASwMfErNTP5Dc5oXGjVT594S-kM2BXOo-EfrZogdYqBk130_provenance.
- NP404805.RASwMfErNTP5Dc5oXGjVT594S-kM2BXOo-EfrZogdYqBk130_assertion wasGeneratedBy ECO_0000203 NP404805.RASwMfErNTP5Dc5oXGjVT594S-kM2BXOo-EfrZogdYqBk130_provenance.